Olema
San Francisco, US Β· 4 known investors
Olema is a clinical-stage biopharmaceutical company developing novel therapies for metastatic breast cancer and other endocrine-driven cancers, targeting nuclear receptors and mechanisms of acquired resistance. It focuses on improving treatment outcomes for patients living with breast cancer.
BiotechHealthtech
Investors Β· 4
Frequently asked questions
- What does Olema do?
- Olema is a clinical-stage biopharmaceutical company developing novel therapies for metastatic breast cancer and other endocrine-driven cancers, targeting nuclear receptors and mechanisms of acquired resistance. It focuses on improving treatment outcomes for patients living with breast cancer.
- Who are Olema's investors?
- Olema's investors include Avoro Capital Advisors, Bain Capital Life Sciences, Lightspeed Venture Partners, RA Capital.
- Where is Olema headquartered?
- Olema is headquartered in San Francisco, US.